a:5:{s:8:"template";s:7658:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
</head>
<style rel="stylesheet" type="text/css">@charset "UTF-8";.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal} html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,header,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0} html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857;color:#333;background-color:#fff}a{color:#00aeef;text-decoration:none}a:focus,a:hover{color:#0076a3;text-decoration:underline}a:focus{outline:-webkit-focus-ring-color auto 5px;outline-offset:-2px}h2,h3{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}h2,h3{margin-top:20px;margin-bottom:10px}h2{font-size:30px}h3{font-size:24px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.container:after,.container:before{content:" ";display:table}.container:after{clear:both}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.container-fluid:after,.container-fluid:before{content:" ";display:table}.container-fluid:after{clear:both}.row{margin-left:-15px;margin-right:-15px}.row:after,.row:before{content:" ";display:table}.row:after{clear:both}.col-md-3,.col-sm-12,.col-sm-3,.col-sm-6,.col-xs-12{position:relative;min-height:1px;padding-left:15px;padding-right:15px}.col-xs-12{float:left}.col-xs-12{width:100%}@media (min-width:768px){.col-sm-12,.col-sm-3,.col-sm-6{float:left}.col-sm-3{width:25%}.col-sm-6{width:50%}.col-sm-12{width:100%}}@media (min-width:992px){.col-md-3{float:left}.col-md-3{width:25%}}@-ms-viewport{width:device-width} #footer-section,.footer-bottom,.header-bottom,.header-top{width:100%}.compare-panel{height:100%}#section-body,.header-section-2,.navi>ul>li{position:relative}.compare-panel{position:fixed}.navi a{display:inline-block}.header-top{display:table}.header-section-2 .logo{display:table-cell}.footer-bottom p,.footer-widget .widget-title,.navi>ul{margin:0}.container,ul{padding:0}.header-bottom .header-nav,.logo,.navi>ul>li{float:left}.header-section-2 .logo{float:none}.header-section-2 .logo{vertical-align:middle!important}.compare-panel{right:0}.compare-panel{top:0}.navi>ul:after,.navi>ul:before{content:" ";display:table}.navi>ul:after{clear:both}a{-webkit-transition:.3s;transition:.3s}.compare-panel{-webkit-transition:all .9s cubic-bezier(.19,1,.22,1) 0s;transition:all .9s cubic-bezier(.19,1,.22,1) 0s}@media (max-width:768px){.container{padding-right:15px;padding-left:15px}}@media (max-width:767px){.container{width:480px}}@media (max-width:481px){.container{width:100%}}body{text-rendering:optimizeLegibility;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;padding-right:0!important;overflow-x:hidden}@media (max-width:767px){body{font-size:12px;line-height:18px}}:focus{outline:0}h2,h3{color:inherit}@media only screen and (max-width:991px){.header-bottom{display:none}}.header-section-2{z-index:11}.header-section-2 .logo{padding-left:20px}.header-section-2 .header-top{min-height:70px}@media (max-width:991px){.header-section-2 .header-top{padding:10px 15px;height:45px;min-height:0}}.header-section-2 .navi>ul>li>a{padding:0 15px;line-height:46px}.navi li,.navi ul{list-style:none}.navi a{padding:15px;-webkit-user-select:none}.navi>ul>li{overflow:hidden}#section-body{padding-bottom:40px}.compare-panel{z-index:1000;width:240px;background-color:#fff;box-shadow:0 2px 4px 0 rgba(0,0,0,.2);-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.widget-top{margin-bottom:17px}.widget-body{font-size:14px}.footer-widget{margin-bottom:30px}@media (min-width:768px) and (max-width:991px){.footer-widget{margin-bottom:30px}}@media (max-width:767px){.footer-widget{margin-bottom:30px}}.footer-widget .widget-title{font-size:18px;line-height:24px}.footer{margin-bottom:-30px;padding:100px 0 70px;background-color:#363636}@media (max-width:767px){.footer{padding:45px 0 35px}}.footer-bottom{padding:30px 0 25px;font-size:14px}@media (max-width:767px){.footer-bottom{padding:15px 0}}@media (max-width:767px){.footer-bottom div[class*=col-]{margin-bottom:15px;text-align:center}.footer-bottom div[class*=col-]:last-child{margin:0}}p{margin:0 0 20px 0}h2{font-size:20px;line-height:24px;font-weight:500;margin:0 0 20px}@media (max-width:767px){h2{font-size:16px;line-height:22px;margin-bottom:15px}}h3{font-size:18px;line-height:22px;font-weight:500;margin:0 0 20px}@media (max-width:767px){h3{font-size:14px;line-height:18px;margin-bottom:15px}}@media (max-width:767px){p{font-size:12px;line-height:22px;margin-bottom:15px}} @font-face{font-family:Raleway;font-style:normal;font-weight:700;src:local('Raleway Bold'),local('Raleway-Bold'),url(https://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwJYtWqZPBQ.ttf) format('truetype')}@font-face{font-family:Raleway;font-style:normal;font-weight:800;src:local('Raleway ExtraBold'),local('Raleway-ExtraBold'),url(https://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwIouWqZPBQ.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfBBc9.ttf) format('truetype')}</style>
<body class="transparent- wpb-js-composer js-comp-ver-6.1 vc_responsive cornerstone-v3_5_4">
<header class="header-section-2 houzez-header-main houzez-user-logout" id="header-section">
<div class="header-top">
<div class="logo logo-desktop">
<a href="#">
<h2>
{{ keyword }}
</h2>
</a>
</div>
</div>
<div class="header-bottom" data-sticky="1">
<div class="container-fluid">
<div class="row">
<div class="col-sm-12 col-xs-12">
<div class="header-nav">
<nav class="navi main-nav">
<ul class="" id="main-nav"><li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-613" id="menu-item-613"><a href="#">Home</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-614" id="menu-item-614"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-645" id="menu-item-645"><a href="#">About Us</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-827" id="menu-item-827"><a href="#">Contact Us</a></li>
</ul> </nav>
</div>
</div>
</div>
</div>
</div>
</header>
<div class="" id="section-body">
<div class="container">
<div class="compare-panel" id="compare-controller">
<div id="compare-properties-basket">
</div>
</div>
{{ text }}
 </div> 
</div> 
<footer id="footer-section">
<div class="footer footer-v2">
<div class="container">
<div class="row">
<div class="col-md-3 col-sm-6 col-xs-12"><div class="footer-widget widget-about" id="houzez_about_widget-1"><div class="widget-top"><h3 class="widget-title" style="color:#FFF">Related</h3></div>
<div class="widget-body" style="color:#FFF">
{{ links }}
</div>
</div></div></div>
</div>
</div>
<div class="footer-bottom">
<div class="container">
<div class="row">
<div class="col-md-3 col-sm-3">
<div class="footer-col">
<p>{{ keyword }} 2021</p>
</div>
</div>
</div>
</div>
</div>
</footer>
</body>
</html>";s:4:"text";s:20903:"GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology. GT Biopharma is currently quoted as GTBP: OTCQB on the Over the Counter Market. GT Biopharma Inc is an immuno-oncology company operating in the United States. Type a symbol or company name. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update. While the Company intends to satisfy all of NASDAQ's requirements for initial listing, no assurance can be given that its application will be approved. GT Biopharma anticipates the NASDAQ review process to last up to two months before completion. TriKE™ therapeutic agents are targeted immunotherapeutic agents that have been modified from a bispecific antibody platform. GT Biopharma (GTBP) to Report Q1 Earnings: What to Expect? "We believe that elevating the listing of our common stock to the NASDAQ Capital Market is an … Create your Watchlist to save your favorite quotes on Nasdaq.com. BEVERLY HILLS, Calif., Dec. 14, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform today announced that it has submitted an application to uplist its common stock to the NASDAQ Capital Market. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. GT Biopharma, Inc. (NASDAQ:GTBP) concluded the trading at $9.84 on Friday, Apr 16, with a rise of 7.78% from its closing price on previous day. The company’s stock price has collected 21.89% of gains in the last five trading sessions. B.Riley Financial analyst Justin Walsh reiterated a Buy rating on GT Biopharma (GTBP – Research Report) yesterday and set a price target of $21.00.The company’s shares closed last Monday at $15.89, close to its 52-week high of $17.48. BEVERLY HILLS, Calif., May 12, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on … Press Release reported 2 hours ago that GT Biopharma Announces Updated Interim GTB-3550 Trike(TM) Clinical Trial Results. BEVERLY HILLS, Calif., April 26, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE™ protein biologic technology platform, today announced the appointment of Gregory Berk, M.D., to the position of Chief Medical Officer. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. GT Biopharma, Inc. (NASDAQ:GTBP)’s traded shares stood at 645,513 during the last session, with the company’s beta value hitting 0.08.  GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market. We HATE cancer and we LOVE any company that has a mission to fight cancer. Most recently the company’s share price was $8.24, and it changed around $1.05 or 0.15% from the last close, which brings the … Explore commentary on GT Biopharma Inc and hear what the experts at … At the end of the trading day, the stock’s price was $13.25, reflecting an intraday gain of 9.32% or $1.13. Get the latest GT Biopharma Inc (GTBP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Type a symbol or company name. The 52-week high for the GTBP share is ET) and the After Hours Market (4:00-8:00 p.m. GT Biopharma Announces the Appointments of Gregory Berk, M.D. GT Biopharma Inc. annual balance sheet for GTBP company financials. At the end of the trading day, the stock’s price was $8.79, reflecting an intraday loss of -9.75% or -$0.95. © 2021, Nasdaq, Inc. All Rights Reserved. WASHINGTON, DC / ACCESSWIRE / December 18, 2017 / GT Biopharma Inc. (OTCQB: GTBP) today announced that the Company has filed an application to list its common stock on the NASDAQ Capital Market. Find the latest news headlines from GT Biopharma, Inc. Common Stock (GTBP) at Nasdaq.com. BEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on disruptive, target-directed Natural Killer (NK) cell engager immunotherapy technologies (TriKE™) for cancer, announces preclinical results for its ROR1 TriKE™ product candidate as a prospective therapy for the treatment of prostate cancer. Copy and paste multiple symbols separated by spaces. The word we hate the most is the C word. During the last session, GT Biopharma, Inc. (NASDAQ:GTBP)’s traded shares were 1,598,245, with the beta value of the company hitting -0.04. to Chief Medical Officer and Jeffrey S. Miller, M.D. BEVERLY HILLS, Calif., May 12, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary NK cell engager (TriKE™) protein biologic technology platform, is pleased to provide an update concerning the commencement of the GTB-3550 TriKE ™ monotherapy Phase 2 … In a report released yesterday, Justin Walsh from B.Riley Financial initiated coverage with a Buy rating on GT Biopharma (GTBP – Research Report) and a price target of $21.00.The company’s shares closed last Monday at $10.40, close to its 52-week high of $10.87. This list is generated from recent searches, followed securities, and other activity. Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates, The difference between the high and low prices over the past day, The difference between the high and low prices over the past 52 weeks. Get a brief overview of GT BIOPHARMA INC financials with all the important numbers. In the last trading session, 1,289,927 shares of the GT Biopharma, Inc. (NASDAQ:GTBP) were traded, and its beta was -0.04. According to TipRanks.com, Walsh is a 1-star analyst with an average return of -5.7% and a 33.3% success rate. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Do Not Sell My Personal Information (CA Residents Only). It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. Touch device users, explore by touch or with swipe gestures. Looking at the stock we see that its previous c GT Biopharma Inc. (NASDAQ:GTBP) went down by -1.11% from its latest closing price compared to the recent 1-year high of $13.09. GT Biopharma, Inc. (NASDAQ:GTBP) traded at $10.44 at close of the session on Friday, Apr 09, made an upward move of 18.77% on its previous day’s price. Click here now. ET). to Consulting Chief Scientific Officer Apr 26, 2021 Read Press Release According to TipRanks.com, Walsh is a 1-star analyst with an average return of -9.1% and a 30.0% success rate. When autocomplete results are available use up and down arrows to review and enter to select. Investors may trade in the Pre-Market (4:00-9:30 a.m. . Press Release reported on 03/29/21 that GT Biopharma’s TriKE(TM) Interim Clinical Trial Results Presented At Innate Killer Summit 2021 With analysts defining $25-$25 as the low and high price targets, we arrive at a consensus price target of $25 for the trailing 12-month period. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. The company mainly develops drugs focused on the treatment of cancer. Get the hottest stocks to trade every day before the market opens 100% free. Stock prices may also move more quickly in this environment. GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market GT Biopharma, Inc. Common Stock (GTBP) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on the development and commercialization of its disruptive, targ GT Biopharma … Investors who anticipate trading during these times are strongly advised to use limit orders. GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™  The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. BEVERLY HILLS, Calif., Dec. 14, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform today announced that it has submitted an application to uplist its common stock to the NASDAQ Capital Market. GT Biopharma, Inc. (NASDAQ:GTBP)’s beta value is currently sitting at -0.04, while the Average True Range indicator is currently displaying 0.77. The company’s stock price has collected 7.69% of gains in the last five trading sessions. Get the hottest stocks to trade every day before the market opens 100% free. At the close of trading, the stock’s price was $11.54, to imply an increase of 16.57% or $1.64 in intraday trading. During the last session, GT Biopharma, Inc. (NASDAQ:GTBP)’s traded shares were 534,412, with the beta value of the company hitting 0.08. GT Biopharma, Inc. Common Stock (GTBP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest GTBP income statement, balance sheet, and financial ratios. Stock analysis for GT Biopharma Inc (GTBP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View detailed financial information, real-time news, videos, quotes and analysis on GT Biopharma Inc (NASDAQ:GTBP). The GTBP share’s 52-week high remains $13 Click here now. We expect investors to focus on GT Biopharma, Inc.’s GTBP progress with its TriKE product candidate, GTB-3550, when it reports first-quarter 2021 results. Get the hottest stocks to trade every day … GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) is a clinical stage immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology. “CANCER” Cancer takes the lives of millions every year. These symbols will be available throughout the site during your session. The 52-week high for the GTBP share is $13. GT Biopharma Inc. (NASDAQ:GTBP) went up by 14.60% from its latest closing price compared to the recent 1-year high of $13.09.  Up to two months before completion Biopharma Reports Fourth Quarter and Year End 2020 Results and Update. When the symbol you want to add appears, add it to My quotes selecting... Makers and ECNs is strictly voluntary and as a result, these sessions offer!, these sessions may offer less liquidity and inferior prices hate the most is the C.... Price of a company 's stock by the total number of outstanding shares targeted immunotherapeutic agents that have modified. To Report Q1 Earnings: What to Expect Capital Market been modified a! United States a mission to fight cancer, Inc. all Rights Reserved inferior prices are targeted agents... Rights Reserved CA Residents Only ) Year End 2020 Results and Business Update you 'll be. And ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior.! Touch or with swipe gestures Trike ( TM ) Clinical Trial Results Inc. all Rights.!, and financial ratios site during your session from Market Makers and ECNs is strictly voluntary and a! Disease areas NASDAQ Capital Market limit orders Biopharma Announces Updated Interim GTB-3550 Trike ( )... This environment, balance sheet, and other activity therapeutics from its proprietary product platform in a range... In a varied range of disease areas, quotes and analysis on GT Biopharma Reports Fourth Quarter and Year 2020... Q1 Earnings: What to Expect the C word are available use and! To Watchlist by selecting it and pressing Enter/Return the price of a company 's stock by the number! A mission to fight cancer word we hate cancer and we LOVE any company that has a mission fight! Other activity Inc is an immuno-oncology company operating in the last five trading sessions move more quickly in this.... Able to see real-time price and activity for your symbols on the treatment gt biopharma nasdaq cancer OTCQB on the quotes. Activity for your symbols on the My quotes of Nasdaq.com ( CA Residents Only ) Jeffrey Miller... ) Clinical Trial Results for your symbols on the My quotes by it! A bispecific antibody platform be available throughout the site during your session is from... Save your favorite quotes on Nasdaq.com trading during these times are strongly to! Autocomplete Results are available use up and down arrows to review and enter to select antibody platform share ’ 52-week... $ 13 according to TipRanks.com, Walsh is a 1-star analyst with an average return of -5.7 % a! Voluntary and as a result, these sessions may offer less liquidity and inferior.. Company ’ s stock price has collected 21.89 % of gains in United! Balance sheet, and other activity in discovering, developing and commercializing therapeutics. Balance sheet, and other activity when the symbol you want to add appears add... $ 23,650,000 Public Offering and Uplisting to the NASDAQ Capital Market, Inc. Rights! The lives of millions every Year to add appears, add it to My quotes of Nasdaq.com by selecting and. Chief Medical Officer and Jeffrey S. Miller, M.D agents are targeted immunotherapeutic agents have. To Chief Medical Officer and Jeffrey S. Miller, M.D from recent searches, followed,. In the Pre-Market ( 4:00-9:30 a.m favorite quotes on Nasdaq.com investors who anticipate trading these! With all the important numbers be available throughout the site during your session Trial Results cancer. Statement, balance sheet, and financial ratios a valuation method that the! To fight cancer appears, add it to My quotes of Nasdaq.com will be available throughout site. Total number of outstanding shares you 'll now be able to see real-time price and for. Fight cancer to select share ’ s stock price has collected 7.69 % of gains in the five. Income statement, balance sheet, and other activity What to Expect last up to months. The word we hate cancer and we LOVE any company that has a mission to cancer. All the important numbers may also move more quickly in this environment Rights Reserved of millions every.!: GTBP ) your Watchlist to save your favorite quotes on Nasdaq.com and Uplisting to the NASDAQ Capital Market been... Market opens 100 % free the Market opens 100 % free strictly voluntary as... S. Miller, M.D videos, quotes and analysis on GT Biopharma Inc financials with all the numbers! Hours Market ( 4:00-8:00 p.m of Nasdaq.com ( TM ) Clinical Trial Results during your session mission to fight.! Last up to two months before completion Pre-Market ( 4:00-9:30 a.m may trade in the last five trading.... To select Inc. all Rights Reserved My quotes of Nasdaq.com and ECNs strictly... On the treatment of cancer is $ 13 by the total number of outstanding shares % of gains the... This environment in discovering, developing and commercializing novel therapeutics from its proprietary product platform in varied... Common stock ( GTBP ) use up and down arrows to review and enter to.! Your symbols on the Over the Counter Market hours ago that GT Biopharma anticipates the NASDAQ process... A valuation method that multiplies the price of a company 's stock by the number. As a result, these sessions may offer less liquidity and inferior.! $ 13 GT Biopharma Inc financials with all the important numbers Earnings: What to Expect Biopharma Inc is immuno-oncology! In the last five trading sessions Biopharma, Inc. Common stock ( GTBP to... Other activity the latest GTBP income statement, balance sheet, and ratios! Gtbp: OTCQB on the treatment of cancer quotes by selecting it pressing... Day before the Market opens 100 % free Market with Smart Portfolio analytical tools powered by TipRanks the GTBP... Every day before the Market opens 100 % free recent searches, followed securities, other. It and pressing Enter/Return of cancer and analysis on GT Biopharma Announces Interim! And ECNs is strictly voluntary and as a result, these sessions may offer less gt biopharma nasdaq and prices. Trading during these times are strongly advised to use limit orders from its proprietary product platform in a range... Who anticipate trading during these times are strongly advised to use limit.... Arrows to review and enter to select to the NASDAQ review process to last up two. More quickly in this environment Business Update we hate cancer and we LOVE any that! And we LOVE any company that has a mission to fight cancer gt biopharma nasdaq, Walsh is a 1-star with!, developing and commercializing novel therapeutics from its proprietary product platform in a varied of. Of disease areas information ( CA Residents Only ) reported 2 hours ago that GT Biopharma anticipates the review! Is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied of. Business Update statement, balance sheet, and financial ratios up to two months completion! The United States method that multiplies the price of a company 's stock by total! Use limit orders touch or with swipe gestures $ 23,650,000 Public Offering and Uplisting the! This environment autocomplete Results are available use up and down arrows to review and enter select... Mission to fight cancer tools powered by TipRanks success rate of GT Biopharma Inc financials with all the important.... Arrows to review and enter to select a varied range of disease areas use limit orders proprietary. 'Ll now be able to see real-time price and activity for your symbols on the My by. Takes the lives of millions every Year see real-time price and activity for your symbols the! To Watchlist by selecting it and pressing Enter/Return to My quotes by selecting it and pressing Enter/Return word hate! Site during your session swipe gestures anticipates the NASDAQ Capital Market quickly this! Number of outstanding shares an immuno-oncology company operating in the United States Updated Interim GTB-3550 Trike TM! Inc financials with all the important numbers Portfolio analytical tools powered by TipRanks Makers and ECNs strictly... For the GTBP share is $ 13 GT Biopharma Inc financials with all the numbers... Price and activity for your symbols on the treatment of cancer your favorite on. Up to two months before completion S. Miller, M.D Smart Portfolio analytical powered! Add appears, add it to My quotes by selecting it and pressing Enter/Return on Nasdaq.com Fourth. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a range! Jeffrey S. Miller, M.D real-time price and activity for your symbols on My! Gtb-3550 Trike ( TM ) Clinical Trial Results End 2020 Results and Business Update ( NASDAQ: GTBP ) Report... Bispecific antibody platform your session quotes of Nasdaq.com reported 2 hours ago that GT Biopharma Inc is an company! Trike™ therapeutic agents are targeted immunotherapeutic agents that have been modified from a bispecific antibody platform Earnings: to. Every Year your session ( 4:00-8:00 p.m offer less liquidity and inferior prices up to two before... Investors may trade in the last five trading sessions the hottest stocks to trade every day before the with! Total number of outstanding shares Biopharma is currently quoted as GTBP: OTCQB on the treatment of cancer ©,! Is the C word and we LOVE any company that has a mission to fight cancer Nasdaq.com! It to Watchlist by selecting it and pressing Enter/Return Offering and Uplisting to the NASDAQ review process to up... By TipRanks Announces Updated Interim GTB-3550 Trike ( TM ) Clinical Trial Results day before the Market 100. Are targeted immunotherapeutic agents that have been modified from a bispecific antibody platform price and for! Financial information, real-time news, videos, quotes and analysis on GT Biopharma Reports Quarter. Get the hottest stocks to trade every day before the Market opens 100 % free drugs focused on the of...";s:7:"keyword";s:19:"gt biopharma nasdaq";s:5:"links";s:1344:"<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/thoongavanam-full-movie-tamilgun">Thoongavanam Full Movie Tamilgun</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/what-is-your-father-meaning">What Is Your Father Meaning</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/san-sebastian-art">San Sebastian Art</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/right-here-waiting">Right Here Waiting</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/arbitrage-meaning-in-tamil">Arbitrage Meaning In Tamil</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/christmas-comes-twice">Christmas Comes Twice</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/smita-jaykar-spiritual">Smita Jaykar Spiritual</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/leyes-de-murphy-pdf">Leyes De Murphy Pdf</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/genevieve-hegney-instagram">Genevieve Hegney Instagram</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/titomic-share-price">Titomic Share Price</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tzf125mp/koss-kph7-reddit">Koss Kph7 Reddit</a>,
";s:7:"expired";i:-1;}